| Argos Therapeutics' Arcelis™ Immunotherapy for the Treatment of Renal Cell ... - PR Newswire (press release) |
|
|
PR Newswire (press release) DURHAM, NC, June 1, 2011 /PRNewswire/ -- Argos Therapeutics announced today that its Arcelis™ immunotherapy for the treatment of renal cell carcinoma (RCC), AGS-003, in combination with sunitinib demonstrated a strong immunologic response that ... Argos Therapeutics' Arcelis™ Immunotherapy for the Treatment of Renal Cell |